Novonesis Q3 Adjusted EBITDA €437.1M vs €432.9M Consensus
Novonesis reported Q3 adjusted EBITDA of €437.1 million, compared with company consensus of €432.9 million.
Novonesis reported Q3 adjusted EBITDA of €437.1 million, compared with company consensus of €432.9 million.